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Summary. Health inequalities are the unfair and avoidable differences in people’s health be-
tween different social groups. These inequalities have a huge influence on people’s lives, par-
ticularly those who live at the poorer end of the socio-economic spectrum, as they result in
prolonged ill health and shorter lives. Most studies estimate health inequalities for a single dis-
ease, but this will give an incomplete picture of the overall inequality in population health. Here
we propose a novel multivariate spatiotemporal model for quantifying health inequalities in Scot-
land across multiple diseases, which will enable us to understand better how these inequalities
vary across disease and have changed over time. In developing this model we are interested
in estimating health inequalities between Scotland’s 14 regional health boards, who are re-
sponsible for the protection and improvement of their population’s health. The methodology is
applied to hospital admissions data for cerebrovascular disease, coronary heart disease and
respiratory disease, which are three of the leading causes of death, from 2003 to 2012 across
Scotland.
Keywords: Bayesian modelling; Disease mapping; Health inequalities; Multivariate
spatiotemporal correlation
1. Introduction
Disease risk is not constant over space and time, and is often impacted by exposure to risk
inducing behaviour such as consumption of alcohol. Poverty and, more generally, deprivation
are major factors in the spatial variation that is observed in the risk of disease, with more highly
deprived areas usually exhibiting elevated levels of disease risk (McCartney, 2012). This differ-
ence in disease risk between social groups living in different areas is known as a health inequality
(or inequity). Importantly, health inequalities refer to the unfair and avoidable differences in
people’s health, and are based largely on socio-economic factors such as income, wealth and
education. They are fundamentally driven and shaped by economics, social policy and politics,
which in turn lead to an unequal distribution of income, power and wealth. On a global level the
world’s poorest people tend to have the worst health; for example, the average life expectancy
in Japan is 83.7 years, compared with 50.1 years in Sierra Leone (World Health Organization,
2016).
Health inequalities also exist within countries and are seen in countries of all ranges of
incomes. There is evidence which shows that individuals who live at the poorer end of the socio-
Address for correspondence: Eilidh Jack, School of Mathematics and Statistics, University of Glasgow, Univer-
sity Place, Glasgow, G12 8QQ, UK.
E-mail: e.jack.1@research.gla.ac.uk
1062 E. Jack, D. Lee and N. Dean
economic spectrum exhibit poorer health regardless of the wealth of the country (World Health
Organization, 2008). The ﬁrst major report on health inequality in the UKwas the Black report
(Black et al., 1982), which was commissioned by the Labour Government in 1977. The report
showed the unequal distribution of ill health and death across the UK and concluded that
these inequalities were due mainly to social inequalities affecting health. The Acheson report
(Acheson, 1998) conﬁrmed ﬁndings from the Black report that the ‘weight of scientiﬁc evidence
supports a socio-economic explanationof health inequalities’. Following thepublicationof these
reports it became widely recognized that ‘social class’ had a strong bearing on life expectancy.
This is illustrated in Table 2.1 of Bartley (2016) which shows standardized mortality ratios by
Registrar-General’s social class in men aged 15–64 years, with a standardized mortality ratio
for class I (professional) of 66 compared with 189 for class V (unskilled manual) in 1991. More
recently, the Marmot (2010) review’s key policy objectives focused on the social determinants
of health.
Reports such as these have aided the development of several social models, which differ from
statistical models in that the aim is to explain the behaviours of the people who are involved
in a certain event or activity. Three of the most common models of explanation for health
inequalities, which were described in detail in Bartley (2016), are behavioural, material and
psychosocial.Very brieﬂy, behavioural and ‘cultural’ explanations refer to the existence of health
inequality due to differences in lifestyle between social groups,most notably smoking, exercising
for leisure and quantity of fats, sugars and salt in the diet. The psychosocial model identiﬁes
the ‘psychosocial risk factors’ which impact health, including social support, autonomy at work
and the balance between home and work (Hemmingway and Marmot, 1999). The materialistic
model recognizes the signiﬁcance of
‘the ... diffuse consequences of the class structure: poverty, work conditions ... and deprivation in its
various forms in the home and immediate environment, at work, in education and the upbringing of
children and more generally in family and social life’
(Black et al., 1982). Much of the literature attempts to use a combination of these three models
when attempting to explain the causes of health inequality.
In this study we focus on Scotland for several reasons. First of all, Scotland has very poor
health for a European country, with the lowest and most slowly improving life expectancy
compared with all other western European countries (Walsh et al., 2016). Scotland also has
the widest health inequalities in western Europe (Popham and Boyle, 2011). For example, in
2015 men living in the most afﬂuent areas in Scotland experienced 23.8 more years of ‘good
health’ compared with those living in the most deprived areas (22.6 years for women; NHS
Health Scotland (2015)). On an individual level, this is a tale of human tragedy, with too many
Scots experiencing poor health and dying prematurely as a direct result of health inequalities.
These inequalities in health also have huge economic repercussions for Scotland and place an
enormous burden on the National Health Service (NHS). For example, it has been estimated
that, if the death rate across Scotland fell to the level of the least deprived areas, the economic
beneﬁt could exceed £20 billion (Audit Scotland, 2012).
Reducing health inequalities has been a priority for the Scottish Government for many years,
and in 2007 they established the Ministerial Task Force for Health Inequalities whose aim
was ‘to identify and prioritise practical actions to reduce the most signiﬁcant and widening
health inequalities’ (Scottish Government, 2008). In the current paper we focus in partic-
ular on health inequalities between Scotland’s 14 regional health boards (HBs), who are
responsible for the protection and improvement of their populations’ health. In 2011–2012 the
Scottish Government allocated around £170 million to the HBs to address health inequalities
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directly, giving them direct responsibility for tackling this problem (Audit Scotland, 2012).
There have been many reports by ofﬁcial bodies such as the Scottish Government, NHS
Scotland and Audit Scotland (Scottish Government, 2008; NHS Health Scotland, 2015; Audit
Scotland, 2012) on Scotland’s health inequalities, with a focus on ways to reduce these in the
future.
On the research side, Taulbut et al. (2014) compared west–central Scotland with other post-
industrial regions of Europe, and Leyland et al. (2007) examined patterns in, and causes of,
inequalities for regions of Scotland. Comparisons between other European countries and Scot-
land were the focus of Walsh et al. (2016), but they concentrated on explaining Scotland’s,
and particularly Glasgow’s, excess mortality. However, this research collectively lacks a detailed
analysis of health inequalities for multiple diseases at the small area scale in Scotland, which is
the focus of this paper.
There is an extensive literature in modelling spatiotemporal variation in the risk of a single
disease from small area data, with many approaches being based on conditional auto-regressive
(CAR) models (Besag et al., 1991). Many adaptations of this model have been proposed since,
including Bernardinelli et al. (1995), who utilized correlated linear time trends for each area.
MacNab and Dean (2002) extended this to non-linear trends, and Knorr-Held (2000) utilized
temporal effects, spatial effects and a space–time interaction. Separately, many models have
been proposed for multivariate disease mapping in a purely spatial setting, using multivariate
CAR spatial models, including Kim et al. (2001), Carlin and Banerjee (2003) and Gelfand and
Vounatsou (2003).
However, very few multivariate space–time models have been proposed for modelling the
risk of multiple diseases in space and time simultaneously. Examples include Richardson et al.
(2006), who proposed a shared component model for diseases, which was extended to allow for
more than two diseases by Tzala and Best (2008). Alternatives were proposed by Quick et al.
(2017) using non-separable multivariate space–time CAR models. Additionally Bradley et al.
(2015, 2018) proposed a multivariate spatiotemporal mixed effects model which would allow
them to model high dimensional data sets efﬁciently.
This paper adds to this small literature by proposing a novel spatiotemporal multidisease
model for quantifying health inequalities in Scotland. Ourmain focus is answering the following
questions of interest.
(a) Are there health inequalities between Scotland’s HBs and how are these changing over
time and over disease?
(b) Within anHB, howdo average levels of risk and temporal trends change between diseases?
(c) How are health inequalities changing over time in small areas in Scotland across multiple
diseases?
(d) What effect do the covariates have on risk and how does this change by disease?
(e) Are there some areas which have high risk for all three diseases?
We answer these questions in Section 4, whereas the data and methodology are respectively
presented in Sections 2 and 3. Finally, Section 5 provides a discussion of the conclusions drawn
and possible future work.
The data that are analysed in the paper and the programs that were used to analyse them can
be obtained from
https://rss.onlinelibrary.wiley.com/hub/journal/1467985x/series-
a-datasets
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2. Scotland study
2.1. Study region
The study region is Scotland, UK, which has a population of around 5.3 million. It is split into
n=1235 non-overlapping small administrative areas known as intermediate geographies (IGs)
(http://www.gov.scot/Publications/2005/02/20732/53083), which contain on
average 4000household residents. The 14HBswhichwe are interested in quantifying inequalities
between are a range of sizes, both geographically and in terms of population. The HBs with
the smallest populations are two of the island boards, Orkney and Western Isles, with 2012
population estimates of 21530 and 23210 respectively. In contrast, Greater Glasgow and Clyde,
and Lothian are the most populated HBs despite their relatively small geographical area, with
populations of 1217025 and 843733 respectively. This is because both of Scotland’s largest
cities are in these HBs. Glasgow and Edinburgh respectively. Further details about the HBs are
provided in Section 2 of the on-line supplementary material.
2.2. Disease data
The disease data for each IG are yearly counts of the numbers of hospital admissions for three
of Scotland’s biggest killers (ScotPHO, 2016), namely cerebrovascular disease, coronary heart
disease and respiratory disease, for the years 2003–2012 in each IG. In the middle of our time
period (2007) the death rates per 100000 for Scotland were 103.2, 180.7 and 142.5 for the three
diseases respectively. Coronary heart disease is deﬁned by using the international classiﬁcation
of diseases version 10 codes I20–I25, whereas the codes are J00–J99 and R09.1, and I60–I69
and G45 for respiratory and cerebrovascular disease respectively.
The 10-year time period was chosen for a few reasons. Firstly, the data for these years are
freely available from the Scottish Statistics web site (http://statistics.gov.scot/).
Secondly, during this period there were several key policy changes in Scotland which may have
either directly or indirectly helped to reduce health inequalities in Scotland. For example, The
Smoking Health and Social Care (Scotland) Act 2005 banned smoking in any enclosed public
space in Scotland from March 26th, 2006, which is of interest since smoking has been proven to
increase the likelihood of an individual developing heart disease, stroke and respiratory disease
(US Department of Health and Human Services, 2014).
To adjust for age and sex differences in the populations in each IG, the expected numbers of
hospital admissionswere calculated separately for each disease by using indirect standardization
based on age- and sex-adjusted rates for thewhole of Scotland.Given that one of the goals of this
analysis is to investigate temporal trends in disease risk, the rates for the year 2006–2007 were
used to calculate the expected values for all years. Letting i denote IG .i=1, : : : , 1235/, t denote
year since 2003 .t =1, : : : , 10/ and d denote disease (d =1, cerebrovascular disease; 2, coronary
heart disease; 3, respiratory disease), the simplest measure of disease risk is the standardized
incidence ratio Rˆitd =Yitd=Eitd , where Yitd is the observed number of hospitalizations and Eitd
is the expected number of hospitalizations. Values of the standardized incidence ratio greater
than 1 represent elevated levels of disease risk, and values less than 1 correspond to decreased
levels of disease risk; for example, a standardized incidence ratio of 1.2 corresponds to a 20%
increase in risk.
To illustrate the temporal trends byHB,which is a key goal of this study, Fig. 1 shows boxplots
of the standardized incidence ratio values for the IGs in each HB at each time point for each
disease. From this it can clearly be seen that the risk of disease is not constant within an HB
over the time period. Similar trends can be seen across some of the HBs in each disease; for
examplemanyof theHBs for cerebrovascular disease and coronary heart disease have decreasing
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Fig. 1. Boxplots of standardized incidence ratios for (a) cerebrovascular disease, (b) coronary heart disease
and (c) respiratory disease for IGs in each HB at each year (2003–2012): A, Ayrshire and Arran; B, Borders;
F, Fife; G, Greater Glasgow and Clyde; H, Highland; L, Lanarkshire; N, Grampian; R, Orkney; S, Lothian; T,
Tayside; V, Forth Valley; W, Western Isles;Y, Dumfries and Galloway; Z, Shetland
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trends, whereas for respiratory disease many of the HBs have an increasing trend. However, not
all the HBs within a disease follow these general patterns; for example for respiratory disease
Highland H, Grampian N, Forth Valley V and Dumfries and Galloway Y all seem to have
reasonably constant risks over the time period. This highlights that within an HB the trends
are not consistent within a disease, which suggests using HB and disease-speciﬁc trends in the
modelling. Finally, the plots show much more variability over time for the three island HBs
Orkney R, Western Isles W and Shetland Z, due to the small number of IGs in these HBs.
To assess the presence of spatial variation in the data for each disease, Fig. 2 shows the stan-
dardized incidence ratios across IGs in Scotland in 2006 for cerebrovascular disease, coronary
heart disease and respiratory disease. From these maps we can see that the spatial patterns for
each disease are not the same. Both coronary heart disease and cerebrovascular disease have
more areas in northern Scotland with high disease risk than does respiratory disease. This sug-
gests having disease-speciﬁc spatial risk surfaces in the modelling. Animations of these maps
for each disease showing the changes over time can be found in section 3 of the on-line supple-
mentary material.
2.3. Covariate data
Potential covariates were identiﬁed to help to describe the spatial variation in disease risk across
Scotland, which enables us to explore the unexplained excess risk in the HBs after account-
ing for these known factors. Firstly, the percentage of 16–64-year-olds claiming Job Seeker’s
Allowance is used as a proxy measure of deprivation, since it is well known that higher levels
of socio-economic deprivation are linked to increased risk of disease (Audit Scotland, 2012).
Given that there is also evidence that a person’s ethnicity can have an inﬂuence on the risk of
certain diseases (Scottish Government, 2012), the percentage of the population of Asian eth-
nicity and the percentage of the population of black ethnicity are also included as potential
explanatory variables. Both of these covariates are highly skewed to the right with many nearly
zero values, and so a log-transformation was applied. Finally, an urban–rural factor was in-
cludedusing the ScottishGovernment’s urban–rural twofold classiﬁcationwhich canbe found at
http://www.gov.scot/Topics/Statistics/About/Methodology/UrbanRural
Classification. This was chosen as an indication of access to hospitals, as perhaps those
who live in rural areas are less likely to be admitted to hospital if they live in remote areas where
hospitals are difﬁcult to reach.
2.4. Exploratory analysis
To assess the presence of residual spatial correlation in the data, a Poisson generalized linear
model was ﬁtted to the data for 2003 for each disease separately, with the covariates described.
Moran’s I (Moran, 1950) statisticswere then calculated by using the residuals from thesemodels,
and the results show that for all three diseases strong spatial correlation was present, with
Moran’s I -statistics of 0.107, 0.227 and0.241 for cerebrovascular, coronaryheart and respiratory
disease respectively, with signiﬁcant associated p-values less than 0.001 for all three statistics.
Pairwise correlations were also calculated between the residuals for each disease, with a corre-
lation of 0.211 between cerebrovascular and respiratory disease, 0.216 between cerebrovascular
and coronary heart disease and 0.337 between coronary heart and respiratory disease. This
indicates that there is some residual between-disease correlation in the data, suggesting that
between-disease correlation needs to be modelled. To investigate whether disease-speciﬁc co-
variate effects would be appropriate, the estimated covariate effects from the same Poisson
generalized linear models as before were checked and some differences in these were found. For
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example the covariate log(% of population of Asian ethnicity) showed a signiﬁcant protective
effect for coronary heart disease, a signiﬁcant increased risk effect for respiratory disease and
no signiﬁcant effect for cerebrovascular disease. It is therefore appropriate to include separate
covariate effects for each disease.
Finally, to assess the presence of temporal correlation, the average lag 1 correlation coefﬁcient
was calculated for each disease across the IGs, but given that we have a very short time series
(only 10 time points) the results from this were inconsistent. However, given that the data come
from the same group of people every year, a priori, we would expect there to be temporal
correlation and so we shall account for this in the ﬁnal model.
3. Methodology
We propose a novel multivariate spatiotemporal Bayesian hierarchical model for these data,
with the aim of quantifying how health inequalities have changed over time in Scotland at the
HB level.
3.1. Likelihood model
The ﬁrst level of the hierarchical model that we specify is given by
Yitd ∼Poisson.EitdRitd/, i=1, : : : ,n .=1235/, t =1, : : : ,T .=10/, d =1, 2, D .=3/,
ln.Ritd/=xTi βd +Hh.i/td +φid , h.i/=1, : : : ,H .=14/, (1)
where Yitd andEitd are the observed and expected numbers of hospital admissions in IG i, at time
point t for disease d , whereas Ritd is the risk relative to the expected numbers Eitd . Wemodel the
log-risk with three components, the ﬁrst of which is the p×1 vector of known covariates xi =
.1,xi2, : : : ,xip/, including an intercept term, with disease-speciﬁc regression parameters βd =
.β1d , : : : ,βpd/. Given that we do not have access to temporally varying covariate information we
cannot include this in the model. However, we did consider allowing the regression parameters
to vary over time and disease, i.e.βtd = .β1td , : : : ,βptd/, but the parameter estimates showed little
change over time and can be found in Section 6.1 of the on-line supplementary material. The
prior that was speciﬁed is βd ∼N.0, 100I/, where I is a d × d identity matrix, which is weakly
informative to allow their values to be informed by the data. The remaining two components
are a baseline disease-speciﬁc spatial effect φid , and a disease- and HB-speciﬁc temporal trend
Hh.i/td , where h.i/ denotes that IG i is within HB h. We have chosen not to include temporal
variation in the random effects φid , because we want all temporal variation to be incorporated
in the temporally varying HB effects as these are of key interest.
3.2. Disease-specific spatial effects
In Section 2.4, we found evidence of substantial residual spatial correlations in the data, which
we model via disease-speciﬁc spatial random effects. Spatial correlation is induced into these
random effects via the spatial neighbourhood matrixW , which is an n×n binary matrix, where
wij =1 if two areas share a common border and wij =0 if not. Also wii =0 for all i. However,
there are several island IGs that have no deﬁned neighbours by using this speciﬁcation (six in
total), and these were assigned a single neighbour based on the closest IG.
Since therewas evidence fromFig. 2 that a common spatial surfacemay not be appropriate for
all diseases, we model the multidisease spatial effects φ by a multivariate version of the Leroux
CAR prior (Leroux et al., 2000) given by
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φi|φ−i ∼N
(
ρ
n∑
j=1
wijφj
ρ
n∑
j=1
wij +1−ρ
,
1
ρ
n∑
j=1
wij +1−ρ
Σ
)
, Σ∼ Inverse-Wishart.3, I/,
ρ∼Unif.0, 1/, (2)
where φi = .φi,1, : : : ,φi,D/ and φ−i = .φ1, : : : ,φi−1,φi+1, : : : ,φn/. The parameter ρ controls the
level of spatial correlation in the data, with ρ= 0 corresponding to independence in space
and ρ=1 corresponding to the multivariate extension of the intrinsic CAR prior (Besag et al.,
1991). Disease-speciﬁc spatial correlationsρ= .ρ1,ρ2,ρ3/were considered, but analyses on each
disease separately suggested that a single ρ-parameter was sufﬁcient. The covariance matrixΣ is
included to allow for between-disease correlation. Given that there is no particular reason for an
a priori structure for this matrix, a conjugate inverseWishart prior is assigned toΣ, with weakly
informative hyperparameters to allow these parameters to be estimated mainly by the data.
3.3. Temporally varying health board effects
A key question in our analysis is to investigate the health inequalities between Scotland’s 14
regional HBs, and how these change over time and between disease. Therefore we include
disease-speciﬁc HB temporal trends in the model,Hhd = .Hh1d , : : : ,HhTd/, which are modelled
by the ﬁrst-order auto-regressive process
Hhtd ∼N.αdHh,t−1,d ,σ2d/, σ2d ∼ Inverse-Gamma.0:001, 0:001/, αd ∼Unif.0, 1/, .3/
where Hhtd is the effect for HB h at time point t for disease d. Temporal correlation is induced
via the hyperparameter αd , with αd = 0 indicating independence across time whereas αd = 1
indicates strong temporal dependence. Initially this model allowed the hyperparameters αd and
σ2d to vary by disease and HB; however, in this case the parameters were not well identiﬁed by
the data, and so αd and σ2d varied by disease only. As before, weakly informative priors were
assigned to αd and σ2d to allow their values to be mainly informed from the data.
3.4. Inference and software
To obtain posterior summaries of each parameter, samples were drawn from the posterior
distribution by using Markov chain Monte Carlo simulation using both Gibbs sampling and
Metropolis steps. The Markov chain Monte Carlo algorithm was written in R (R Develop-
ment Core Team, 2014). However, because of the large number of random effects that must
be sampled at each iteration, this part of the estimation, along with the update for the HB
effects, was implemented by using C×× via the R package Rcpp (Eddelbuettel and Franc¸ois,
2011; Eddelbuettel, 2013). Additionally, as W is sparse, we utilized its triplet form to speed
up computation. To make this research reproducible the code and data are also available from
https://github.com/eilidhjack/MVST-software.
4. Results
The multivariate spatiotemporal model that was proposed in Section 3 was applied to the data
that were described in Section 2. Inference is based on a single Markov chain Monte Carlo
chain with 150000 iterations, 50000 of which were discarded for the burn-in period. The chain
was thinned by 5 because of limitations in computer memory and to make the samples closer
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Table 1. Estimates and 95% credible intervals for spatial, temporal and
between-disease correlations
Correlation Posterior 95% credible
median interval
Spatial
ρ 0.432 (0.360, 0.512)
Temporal
α—cerebrovascular disease 0.689 (0.562, 0.799)
α—coronary heart disease 0.870 (0.790, 0.946)
α—respiratory disease 0.833 (0.720, 0.940)
Between-disease
Cerebrovascular and coronary heart disease 0.498 (0.465, 0.525)
Cerebrovascular and respiratory disease 0.559 (0.533, 0.578)
Coronary heart and respiratory disease 0.645 (0.633, 0.658)
to independent, and so the posterior estimates are based on 20000 samples. Convergence was
checked both by examining parameter trace plots and by Geweke diagnostics (Geweke, 1992).
The posterior medians and 95% credible intervals for the spatial and temporal correlation
parameters are shown in Table 1. The posterior median estimate for the spatial correlation
parameter ρ is 0.432, which suggests a moderate level of spatial correlation across Scotland
for the three diseases. A separate temporal correlation parameter αd was estimated for each
disease, and Table 1 shows similar estimates for coronary heart disease and respiratory disease,
with posterior medians of 0.870 and 0.833 respectively. Although the posterior median for
cerebrovascular disease is not as high (0.689), it still shows that the data contain moderate levels
of temporal correlation.
The posterior correlation between diseases is calculated via the covariance matrix Σ and, for
example, the correlation between coronary heart disease and respiratory disease is calculated as
Σ12=
√
.Σ11Σ22/: .4/
Table 1 shows the posterior medians of the between-disease correlations, along with the
95% credible intervals. All pairs of diseases show moderate correlation, with the correlation
between coronary heart disease and respiratory disease being the strongest (0.645), whereas the
correlation between coronary heart disease and cerebrovascular disease is the weakest (0.498).
4.1. Health board effects
To investigate whether there are health inequalities between Scotland’s 14 regional HBs within
each disease and how these are changing over time (question (a), Section 1), Fig. 3 shows the
risk that is associated with each HB for each disease separately, after adjusting for the known
covariates. The risk that is associated with the HBs is deﬁned as
Rhtd =
∑
i∈Ih
πi exp.φid +Hhtd/∑
i∈Ih
πi
,
where Ih is the set of all IGs i belonging to an HB h and πi is the proportion of Scotland’s
population living in IG i. For all diseases it can be seen that there are health inequalities between
the HBs, as there are differences between the estimated HB posterior medians within each
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disease. The risk of disease is not consistent between HBs; nor is it constant over time. For
cerebrovascular disease we see a general decreasing trend, and after around 2007 the trends
seem to level off. We also see a narrowing of the inequality between the HBs with a difference
of 0.554 between the highest and lowest median HB risk in 2003 compared with 0.184 in 2012.
Given that the island boards have signiﬁcantly fewer IGs than the mainland boards, we tend
to see greater variation in risk estimates for these boards over the time period. However, even
when ignoring these boards, there is still a reduction in the inequality between HBs from 0.301
in 2003 to 0.184 in 2012.
For coronary heart disease a much stronger decreasing trend can be seen over almost all the
HBs compared with cerebrovascular disease. We also see a narrowing of the inequality between
the HBs, with a range of medians in 2003 of 0.693 compared with 0.346 in 2012. After removing
the island boards the range in inequality lessens from 0.468 in 2003 to 0.267 in 2012.
Finally, theHBeffects for respiratory disease donot show the samepattern as the previous two
diseases. In general, most HB risks seem to go up over the time period.We also see a widening in
health inequalities between the HBs for this disease, with the range between medians increasing
from 0.373 in 2003 to 0.472 in 2012. However, once the island boards have been removed, the
change in inequality is almost non-existent from 0.333 to 0.329.
We are also interested in comparing how average HB levels and temporal trends change be-
tween diseases within anHB (question (b), Section 1). To answer this, Fig. 4 shows the posterior
medians and 95% credible intervals for the HB effects across time for each disease for the HBs
Fife, Greater Glasgow and Clyde, Grampian and Lothian. (Plots for all 14 HBs can be found
in section 4 of the on-line supplementary material.) There are some HBs where the difference in
risk between the diseases is not large. For example, Fife shows a similar risk of cerebrovascular
and respiratory disease, with posteriormedians below 1 and remaining reasonably constant over
the years. However, coronary heart disease risk shows a decreasing trend with an average risk
and 95% credible intervals entirely above 1 at the start of the time period (and higher than the
other two diseases) but below 1 at the end (and now lower than the other two diseases).
For the other HBs the differences in risk between the diseases is much more obvious. For
example, for Greater Glasgow andClyde there is a very strong decrease in risk of coronary heart
disease until around 2009 when it levels off, a less steep decreasing trend for cerebrovascular
disease, but an increasing trend can be seen for respiratory disease, with risk increasing from
the lowest of all diseases in 2003 to the highest in 2012. Similar trends can be seen for Lothian,
although the magnitudes of the trends are not consistent with Greater Glasgow and Clyde.
Another interesting feature is that the same general trend for each disease is not seen over all the
HBs. For example, although Grampian does show a decreasing trend for cerebrovascular and
coronary heart disease, the difference in the strength of this decrease is not greatly different from
each other although coronary heart disease shows a much stronger decreasing trend compared
with cerebrovascular disease for the other three HBs that are shown here. In fact, Grampian
is the only HB whose risk of coronary heart disease is still higher in 2012 than the risk of
cerebrovascular disease. The trend for respiratory disease in Grampian also does not follow the
general increasing trend, with only a very small increase in risk from 2003 to 2012.
4.2. Overall health inequalities
To investigate whether overall health inequalities have changed over time across the IGs in
Scotland (not just betweenHBs as in Section 4.1) (question (c), Section 1), Fig. 5 shows boxplots
of the posterior median disease risk for all IGs for each disease. Printed above each boxplot is
the interquartile range IQR across all IGs. For cerebrovascular disease we see a general decrease
in the overall trend and in health inequality, which can be seen from the decreasing IQRs, from
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Table 2. Relative risk estimates RR for a 1% or 1-unit increase in each covariate (not
urban or rural covariate) and 95% credible intervals for the covariates in the model†
Covariate Median RR 95% credible interval
Cerebrovascular disease
% 16–64-year-olds claiming Job Seeker’s Allowance 1.060 (1.056, 1.065)
Log(% Asian) 0.998 (0.985, 1.011)
Log(% black) 1.008 (1.002, 1.015)
Rural area 0.977 (0.949, 1.006)
Coronary heart disease
% 16–64-year-olds claiming Job Seeker’s Allowance 1.065 (1.059, 1.070)
Log(% Asian) 0.965 (0.951, 0.980)
Log(% black) 1.001 (0.995, 1.008)
Rural area 0.953 (0.924, 0.983)
Respiratory disease
% 16–64-year-olds claiming Job Seeker’s Allowance 1.105 (1.098, 1.112)
Log(% Asian) 0.985 (0.968, 1.001)
Log(% black) 0.992 (0.985, 1.000)
Rural area 0.997 (0.966, 1.033)
†Covariates where the 95% credible intervals do not contain 0 are highlighted in italics.
0.344 in 2003 to 0.250 in 2012. Similarly, the overall risk of coronary heart disease is decreasing
over time, more quickly at the beginning of the time period and after around 2009 this decrease
shows signs of levelling off. When looking at the IQRs we can see a decrease in health inequality
in coronary heart disease risk, from0.440 in 2003 to 0.279 in 2012,which again ismore noticeable
in the period from 2003 to 2009, after which it levels off. Conversely, for respiratory disease, we
see the opposite effect. Not only is the overall risk increasing over time, but also the inequality is
growing worse, which can be seen from the increase in IQR from 0.382 in 2003 to 0.532 in 2012.
4.3. Covariate effects
To assess the effect that covariates have on risk and how this changes over disease (question (d),
Section 1), Table 2 shows the point estimates (posterior medians) and 95% credible intervals on
the relative risk scale. For cerebrovascular disease themedian relative risk RR for the percentage
of 16–64-year-olds claiming Job Seeker’s Allowance is around 1.060 for a 1% increase; so the risk
of cerebrovascular disease in an IG increases by 6.0% as the percentage claiming Job Seeker’s
Allowance increases by 1%. The effect of this covariate for coronary heart disease is similar
(RR = 1:065), whereas the effect for respiratory disease is much larger with an increase of
around 10.5%. This could be because smoking is one of the main causes of respiratory disease,
with nearly eight out of 10 chronic obstructive pulmonary disease deaths deemed to be a result
of smoking (Centers for Disease Control and Prevention, 2014), and deprived areas exhibit
higher levels of smoking compared with afﬂuent areas (NHS Scotland, 2003a).
The covariate log(% of population of Asian ethnicity) showed no evidence of a relationship
with cerebrovascular or respiratory disease risk.However, for coronary heart disease themedian
RR-estimate is 0.965, suggesting that theremaybeavery small decrease in coronaryheart disease
risk as this covariate increases. This is in line with ﬁndings from a Scottish Government report
(Scottish Government, 2012), which found that those of Chinese ethnicity were the least likely
to be diagnosed with cardiovascular disease (which includes coronary heart disease) compared
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with the national average. In that report those in Indian and Pakistani ethnic groups showed no
difference compared with the national average. In this study, the percentage of population of
Asian ethnicity includes all Asian ethnic groups, which could explain the small protective effect
for this covariate.
Neither coronary heart disease nor respiratory disease shows any evidence of a relationship
between disease risk and log(% of population of black ethnicity). However, log(% of population
of black ethnicity) was found to have a small detrimental effect of cerebrovascular disease risk,
with risk increasing by 0.8% as log(% of population of black ethnicity) increased by 1%. This is
line with ﬁndings that people of black origin are at higher risk of stroke compared with white
people (Stroke Association, 2016).
Finally, there is no evidence that living in a rural or urban area made any difference to
the risk that is cerebrovascular or respiratory disease, but for coronary heart disease the risk
that is associated with urban areas compared with rural areas is 1=0:953= 1:049, i.e. there is
an estimated increased risk of coronary heart disease of 4.9% when living in an urban area
compared with a rural area.
Toassess the sensitivity of the results from thismodel to the choice of covariates, themodelwas
also run with no covariates and the results in terms of risk estimates were practically identical.
Some comparative ﬁgures can be found in section 6.2 of the on-line supplementary material.
4.4. Top intermediate geographies risks
It was of interest to identify which IGs showed the highest risk for each disease, and hence
if there were any which exhibited high risk for more than one disease. We identiﬁed the top
ﬁve highest risk IGs in 2003 and then in 2012 for all three diseases, and when we compared
these IGs across the diseases we note some similarities. For example, the IG Paisley Ferguslie
which is in Renfrewshire (south-west of Glasgow) not only appears in the top ﬁve highest risks
for all diseases in both years but also actually comes out on top for coronary heart disease and
respiratory disease and is second highest for cerebrovascular disease in both years. The IGNorth
Barlanark and Easterhouse South inGlasgow appears in the top ﬁve for cerebrovascular disease
and coronary heart disease for both years. Finally, Drumchapel North in Glasgow appears for
respiratory disease in 2012 aswell as for cerebrovascular disease in both years. These areas which
have extremely high risk for two or all three diseases show the extent of the health inequality that
is experienced in these areas. Ultimately this means that, for the people who live in these places,
the risk of hospitalization from any one of these three diseases is much higher than average. A
table listing these IGs along with posterior medians and 95% credible intervals for their risks is
available in section 5 of the on-line supplementary material.
4.5. Model comparison
To compare our model with an existing model in the literature we decided to ﬁt the model that
was proposed by Quick et al. (2017) to our data. Similarly to our model this model was designed
for multivariate spatiotemporal data; however, unlike our model where the spatial component
and temporal component are built separately, this model allows for spatiotemporal dependence
in the data by using a single set of random effects. The model is as follows:
Yitd ∼Poisson.EitdRitd/,
ln.Ritd/=xTi βd +Zitd +φitd ,
.5/
where Zitd is a spatiotemporal random effect which also accounts for between-disease correla-
tion, and φitd ∼N.0, τ2d /. The results from this model were broadly similar to ours, which can
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be seen in section 6.3 of the on-line supplementary material. Because of the added complexity
of the model that was proposed by Quick et al. (2017) and therefore the large number of extra
parameters (an effective number of parameters PD of 11294 compared with 3045 for our model)
the computational time was far greater than for ours. Given that our aim was quantifying HB
inequalities, our model was more appropriate in this context.
5. Discussion
In this paper a multivariate spatiotemporal model was proposed to estimate health inequalities
in Scotland and how they have changed over time. Themodel included separate covariate effects
for each disease, disease-speciﬁc spatial effects and disease- and HB-speciﬁc temporal trends.
The model was applied to yearly hospital admissions data at the IG level for three of Scotland’s
biggest killers: cerebrovascular disease, coronary heart disease and respiratory disease for the
period 2003–2012.
Themain results of this study are that there has been a decrease in risk for cerebrovascular and
coronary heart disease across the HBs, but this is accompanied by an increase for respiratory
disease. We also found that, even after the covariate effects have been removed, there are still
inequalities in disease risk between the HBs for all three diseases. These inequalities change over
time, and overall they appear to be narrowing for cerebrovascular disease and coronary heart
disease, with a reduction in the range of the median HB risks, ignoring the island HBs, between
the ﬁrst and last time points of 0.142 and 0.191 for each disease respectively. However, these
inequalities show no change for respiratory disease with the corresponding difference being only
0.001.
Overall across the IGs in Scotland we found that health inequalities still exist to quite a
considerable extent and, although there has been a narrowing for cerebrovascular and coronary
heart disease, the inequalities in respiratory disease appear to be growing worse over the time
period that is studied here. Research into the prevalence of respiratory diseases in the UK by the
British Lung Foundation has shown that in 2011 approximately 67% ofUKhospital admissions
from respiratory diseases were due to pneumonia, chronic obstructive pulmonary disease and
acute lower respiratory infections. From these, both pneumonia andmore so chronic obstructive
pulmonary disease have shown increasing numbers of diagnoses over the time period 2004–2012
(BritishLungFoundation, 2013).This increased riskmaybepartially due to increaseddiagnoses,
which in turn will bring about an increase in hospital admissions. The increase in respiratory
disease admissions could also be due to a reduction in competing causes for hospitalization,
given that there has been a reduction in risk of hospitalization for cerebrovascular disease and
coronary heart disease. However, this increase in hospital admissions does not occur uniformly
across all IGs. Instead, we are seeing a greater increase in numbers in IGswhich already had high
risks of respiratory disease, which is driving the increase in the health inequality for this disease.
For example, in 2003 the estimated risk for Langholm and Canonbie (lowest risk IG) was 0.302,
which increased to 0.307 in 2012. In comparison, the estimated risk in 2003 for Paisley Ferguslie
(highest risk IG) was 1.955, which increased to 2.627 in 2012.
There were many signiﬁcant changes to the structure of the health service in Scotland in the
years before and during the time period of our data, which could help to explain some of the
improvements that were observed. In 1997, ‘Designed to care: renewing the NHS in Scotland’
(Scottish Ofﬁce, 1997) was published with the main aim of phasing out the internal market,
integrating services to eliminate duplication and wasteful competition and merging 47 Scottish
trusts into 28. Following the devolution in 1999, ‘Our national health: a plan for action, a plan
for change’ (Scottish Executive, 2000) stated that the health budget in Scotland was due to rise
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from £4:9 billion in 1999–2000 to £6:7 billion in 2003–2004 (which coincides with the start of
our time period). This considerable increase in resources was to be used to build a modernized
health system and to improve the health of Scotland’s population.
In the period 2003–2006 there were several more policy changes which may have contributed
to the results that are found in this paper. First of all in 2003, ‘Partnership for care: Scotland’s
healthWhite Paper’ (NHS Scotland, 2003b) was released, which led to the abolition of the NHS
Trusts in 2004 which were absorbed into the HBs which we have focused on in this paper. The
HBs were given the single tier of governance and accountability and health improvement was
made a priority. This policy change also led to the creation of 40 community health partnerships
which were the vehicle for the planning and delivery of primary and community-based services
(Scottish Government, 2010). The community health partnerships were given the responsibility
(alongwith theHBs) to improve health and to reduce health inequalities and couldwork locally,
not only to tackle smoking, obesity, drug and alcohol misuse etc., but also to work with other
agencies to tackle many of the other social determinants of health.
The national service framework (Scottish Executive, 2005) set out long-term plans for the
NHS in Scotland over the next 20 years. The key message was to look to the population of
Scotland to take more responsibility for their own health and to ‘anticipate and prevent rather
than react’.Another keypiece of legislationduring this timeperiodwasTheSmokingHealth and
SocialCare (Scotland)Act 2005,whichbanned smoking in any enclosedpublic space inScotland
from March 26th, 2006. The ban was described by the Chief Medical Ofﬁcer Mac Armstrong
as bringing ‘far and away the most important improvement in our health in a generation’. In
2007, towards the end of our time period, ‘Better health, better care: action plan’ (Scottish
Government, 2007) was introduced, which viewed patients and the public as ‘partners rather
than recipients of care’.This againoutlines the focusofhelping thepublic to improve their health,
acting proactively rather than reactively, particularly in disadvantaged communities. This shift
in perspective is crucial to tackling the health inequalities that still exist in Scotland truly.
Reducing the size of Scotland’s health inequalities has clearly been a key focus of both the
ScottishGovernment andNHSScotland, withmany of these policy changes directly stating that
an improvement in health inequalities as well as overall health is of importance for Scotland’s
people in future. This paper quantiﬁes these changes, and a concerning feature of our results is
the large number of outliers with high risk estimates in Fig. 5. This further highlights the huge
problem that Scotland faces in their inequality in overall health and that more needs to be done
to target areas which are experiencing much higher risks of disease than the rest of Scotland.
A common problem in areal unit data of this type is that often there are changes to bound-
aries during the time period for which data are available. For example, in 2014 the Scottish
Government released a redrawn version of the IG boundaries and several data sets are publicly
available for which the time period overlaps this boundary change. Using data from before and
after this change would lead to incomparable inference due to spatial misalignment in the data.
This issue could be overcome by utilizing a common latent spatial grid scale and using a data
augmentation approach to estimate the data on this scale.Another area for futureworkwould be
to consider a clustering-based modelling approach, to identify areas exhibiting elevated disease
risks across multiple diseases.
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